Pepducins to modulate CXCR4 and CXCR7 mono-, homo-, and heteromers

Early stage researcher 2 (ESR2) project – Birgit Caspar 
Supervision: Prof S J Hill, Dr S J Briddon, Dr L A Stoddart, Prof B Kellam, Dr M Stocks
Host: UNOTT (UK) – University of Nottingham, School of Life Sciences

I- Project proposal:

Aim:
1. Develop cell penetrating lipidated peptides (pepducins) to target intracellular loops of CXCR4, CXCR7 and heteromers.

2. Map interaction sites of pepducins using site-directed mutagenesis and evaluate pepducin effect on CXCR4 and CXCR7 mono-, homo-, and heteromerization, ligand-binding, (biased) signalling, and trafficking.

Methodology:
To study the effect of pepducins on CXCR4 and CXCR7 receptor dimerization, we will generate tagged (SNAP, GFP, Nanoluc) receptors with specific site directed mutations. Ligand binding will be monitored with fluorescent CXCR4 and CXCR7 ligands and receptor dimerization will be monitored using studies of fluorescent ligand dissociation, bimolecular fluorescence complementation, BRET and TR-FRET. The functional consequences of the interactions of pepducins with CXCR4 and CXCR7 receptors will be monitored using cell lines and standard signalling outputs to monitor for signalling bias. Confocal fluorescence microscopy and automated high content confocal imaging will be used to monitor receptor internalisation and β-arrestin recruitment.
Planned secondments: INSERM (FR), Actelion (CH).

 

II- Requirement candidate:

Required diploma: MSc degree in pharmacology or a related discipline.
Required expertise: cell culture, molecular pharmacology, cell-based assays, biochemistry, molecular biology.
Recommended expertise: GPCR molecular pharmacology, imaging, FRET/BRET based signalling, ligand binding studies.

Key publications:
1. Longden J, Cooke EL, Hill SJ. (2008) Effect of CCR5-receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells. Br J Pharmacol. 153: 1513-1527.

2. Stoddart LA, Vernall AJ, Denman JL, Briddon SJ, Kellam B. Hill SJ. (2012). Fragment screening at adenosine A3-receptors in living cells using a fluorescence-based binding assay. Chem Biol. 19: 1105-1115.

3. Corriden R, Kilpatrick LE, Kellam B, Briddon SJ and Hill SJ (2014) Kinetic analysis of antagonist-occupied adenosine A3-receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism. FASEB J 28: 4211-22.

4. Corriden R, Self T, Akong-Moore K, Nizet V, Kellam B, Briddon SJ, Hill SJ (2013) Adenosine A3 receptors in neutrophil microdomains promote the formation of bacteria-tethering cytonemes. EMBO Rep. 14: 726-732.

Follow us on

The transatlantic ECI GPCR symposium #ECIGPCR is about to start, we are ready!! Thanks to the organizers for their excellent job gathering almost 500 people across the globe! @cyclic_Andreas @NicoleAPerry1 @BenderSci @DesislavaNeshe1

My project will be focused on the role of #CXCR4/ACKR3/GRK2 -governed networks in cancer cell migration and metastasis.

Hello 🙂
I am here to continue the series in which all #ESRs are presenting themselves. I am Viviana Marolda and I am in my first year of PhD. I am #ESR13, originally from Italy, and currently, I am working as a PhD student in @CBMSO_CSIC_UAM, at Universidad Autonoma de Madrid.

Hey twitter!
I am @DehanComez. I am taking over the Oncornet account for a while to start a series of all #ESRs writing about themselves and their projects. I am #ESR5, originally from Turkey and right now I am working as a PhD student in @COMPARE_UoBUoN , @UniofNottingham , UK.

New review on #gpcr structural dynamics out in COSB. Great teamwork with the @JanaSelent group. Thanks to @Lundbeckfonden and @novonordiskfond https://lnkd.in/eyjrA5V

ONCORNET2.0 is the successor to #ONCORNET. You can see some of the work of ESRs from the first ONCORNET in this special issue of @MolPharmJournal from 2019, with reviews on #CXCR4 and #ACKR3 structure and function: https://molpharm.aspetjournals.org/content/96/6

Hi everyone – we’re on Twitter! ONCORNET2.0 is a #MarieCurie ITN of 16 ESRs across Europe studying #chemokine #GPCRs #CXCR4 and #ACKR3 in cancer. Our projects cover molecular dynamics, medchem, #pharmacology through to translational work. Follow us for updates from our ESRs!

Hi everyone!

Public service announcement: our Marie-Curie ITN @ONCORNET1 is on Twitter! The 16 wonderful #ECRs working on the project will soon be Tweeting about #GPCR #chemokine #ECR life and #pharmacology

Please #RT & consider a follow or follow back! 🙏😀

Load More…

Contact details

Please contact us at:
info@oncornet.eu

ONCORNET Coordinator
VU University Amsterdam
The Netherlands